EN

Contactez-nous

Clientèle

Cyclenium Pharma fait désormais partie du groupe de sociétés SpiroChem.

Veuillez contacter SpiroChem pour un aperçu complet des opportunités que la technologie et les bibliothèques de Cyclenium Pharma peuvent offrir et pour discuter du potentiel de collaboration avec Cyclenium.

Cyclenium Pharma Inc.

Siège social et site de recherche

Adresse

7171 rue Frédérick-Banting
Montréal, Québec, H4S 1Z9 Canada

Contact

Téléphone: +41 61 685 9500
Courriel: contact@spirochem.com

Carrières

Pour soutenir l’expansion récente de nos efforts internes et collaboratifs de découverte de médicaments, Cyclenium Pharma est à la recherche de scientifiques créatifs, talentueux et novateurs pour se joindre au personnel exceptionnel de notre site de recherche et développement à Montréal (Québec).

S’il vous plaît postuler via notre page carrières
Important Notice: Please be aware that this website will be transitioning to SpiroChem by the end of the year. After the transition, visitors will be seamlessly redirected to SpiroChem’s official site, where you can continue to find all the information and services you need.#ef3d4e
×

Thomas Fessard

Ph.D., Chief Executive Officer & Chief Scientific Officer

Thomas studied chemistry in France (ENSC, Montpellier) and the UK (UMIST, Manchester) and obtained a PhD degree from the university of Nottingham, UK.

After research appointments at the School of Pharmacy in Nottingham and ETH Zürich, Thomas joined Lipideon Biotechnology AG in 2007. As Head of the Drug Discovery and Chemistry, he lead a multi-disciplinary team that discovered a candidate for pre-clinical investigation (Non-Systemic Cholesterol Absorption Inhibitor).

In 2011, Thomas co-founded SpiroChem AG, Swiss fine chemicals company and serves as CEO of the company.

Thomas has several years of experience in the management of R&D projects, including medicinal chemistry, design of innovative building blocks for drug discovery and development of new process routes.